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For  many  decades,  the  major  function  of mRNA  was  thought  to be  to  provide  protein-coding  information
embedded  in  the  genome.  The  advent  of  high-throughput  sequencing  has  led  to the  discovery  of pervasive
transcription  of eukaryotic  genomes  and  opened  the  world  of  RNA-mediated  gene  regulation.  Many
regulatory  RNAs  have  been  found  to be  incapable  of  protein  coding  and  are  hence  termed  as  non-coding
RNAs  (ncRNAs).  However,  studies  in  recent  years  have  shown  that  several  previously  annotated  non-
coding  RNAs  have  the  potential  to encode  proteins,  and  conversely,  some  coding  RNAs  have  regulatoryrotein-coding
egulatory RNA
NA structure
NA processing
ual function RNA
functions  independent  of the protein  they encode.  Such  bi-functional  RNAs,  with  both  protein  coding  and
non-coding  functions,  which  we  term  as ‘cncRNAs’,  have  emerged  as new  players  in cellular  systems.  Here,
we  describe  the functions  of  some  cncRNAs  identiﬁed  from  bacteria  to humans.  Because  the  functions  of
many RNAs across  genomes  remains  unclear,  we  propose  that  RNAs  be  classiﬁed  as  coding,  non-coding
or  both only  after  careful  analysis  of their  functions.
ublis©  2015  The  Authors.  P
. Introduction
The ‘one gene one enzyme’ hypothesis proposed by Beadle
nd Tatum in 1941 [1] and the elucidation of the double helical
tructure of DNA in 1953 [2] led Crick to propose of the cen-
ral dogma of molecular biology placing RNA at the center of the
irectional information ﬂow from genes to their protein prod-
cts [3]. Subsequent identiﬁcation of messenger RNAs (mRNAs),
daptor RNA molecules (tRNA) and ribonucleoprotein-dependent
atalysis of polypeptide synthesis (rRNA/ribosomes) validated RNA
ersatility and eventually inspired the ﬁrst model of RNA-based
egulatory networks in cells of higher organisms [4–8]. However,
he discovery of cis-regulatory elements in DNA controlling gene
xpression by virtue of their interaction with cognate transcrip-
ion factors captured the imagination and interest of scientists,
nd for many years, the regulatory roles of RNA were largely
gnored.
This protein-centric view of gene regulation was challenged
y the discovery of small regulatory RNAs (e.g., miRNAs) and
ene silencing by RNA interference (RNAi) [9–11]. Subsequently,
he advent of high-throughput sequencing and transcriptome
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analysis showed that thousands of genomic loci undergo transcrip-
tion to produce large transcripts that may  not code for proteins
[12,13] (Fig. 1A). These ﬁndings are supported by the ENCODE
(Encyclopedia of DNA Elements) project which showed that ∼80%
of the mammalian genome is transcribed [14]. Furthermore, the
ratio of non-coding to protein coding transcripts has been proposed
to increase with the complexity of organisms and approximately
95% of human transcripts are thought to be non-coding RNAs [15].
The regulatory functions of long non-coding RNAs (lncRNAs) are
under active investigation by several groups and have been recently
reviewed in [16–18]. The phenomenal scale of the non-protein cod-
ing genome shows that our current understanding of RNA-based
gene regulation is rather cursory. Studies in a variety of organisms
over the last two  decades suggest that RNA molecules contain many
more cis- and trans-regulatory functions than previously thought.
Although initially lncRNAs were thought to function strictly as
RNAs and not code for proteins, recent studies have showed that
many previously annotated non-coding RNAs can recruit ribo-
somes and encode short peptides [19–21]. In addition, emerging
evidence suggests that even protein coding mRNAs can have struc-
tural and/or regulatory functions independent of the protein they
encode. [22]. These additional functions of RNA may  seem surpris-
ing, but are not completely unexpected in light of the view that all
current forms of life might have evolved from an RNA world [23,24].
RNA is a versatile molecule in that RNA can store genetic informa-
tion similar to DNA, and can also act as a catalyst similar to proteins
[25,26]. In this review, we focus on bi-functional RNAs with both
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
P. Kumari, K. Sampath / Seminars in Cell & Developmental Biology 47–48 (2015) 40–51 41
Fig. 1. Schematic showing various classes of non-coding RNAs. (A) Transcription: then and now. The conventional concept of transcription suggested that only speciﬁc loci in
the  genome are transcribed to code for proteins while current understanding points toward pervasive transcription of the genome and wide spread occurrence of non-coding
RNAs.  The schematic shows a genomic region with two  genes, A (exons in blue) and B (exons in yellow). According to the old concept there is no transcription in the intergenic
region between genes A and B. The current concept supports the presence of intergenic ncRNAs (purple, between gene A and B), intronic ncRNAs (green, between exon II
and  III of gene A) and antisense ncRNA (orange, in opposite orientation in exon III of gene A). Alternative splicing may also lead to different isoforms of RNAs as shown in
the  second isoform of gene A which lacks exon II. (B) Crosstalk between coding and non-coding RNAs. The transcriptome is more complex than anticipated. Protein coding
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are-mRNAs can give rise to non-coding RNAs. Long non-coding RNAs can encode for
nterpretation of the references to color in this ﬁgure legend, the reader is referred 
rotein coding and non-coding roles (cncRNAs). cncRNAs, carrying
oth protein coding and RNA-intrinsic functions, call for reviewing
he concept where mRNAs were considered a passive step in the
ransition of genetic information from DNA to protein. These dual
unction RNAs also present a potential evolutionary link between
RNAs and ncRNAs (miRNA, endo-siRNA, piRNA, lncRNA, etc.),
hich were previously thought to be inherently different (Fig. 1B).
ere, we describe cncRNAs from a variety of organisms ranging
rom bacteria to humans, with emphasis on the structural or regu-
atory functions of protein-coding RNAs with roles in development
nd disease. peptides and protein-coding mRNAs can have additional regulatory functions. (For
 web  version of this article.)
2. Small regulatory RNAs in bacteria
Small non-coding RNAs have been shown to regulate post-
transcriptional gene expression in all kingdoms of life, including
bacteria. Bacterial genomes encode a large number of small trans-
cripts (sRNAs) in the range of 50–350 nucleotides. Bacterial sRNAs
can be grouped in two classes: (1) antisense RNAs that function
via base-pairing with their targets, and (2) protein-binding sRNAs
[27]. Most bacterial antisense RNAs are non-coding and are also
called ‘ribo-switches’ or ‘ribo-regulators’. However, in recent years
it has become evident that some antisense RNAs can also encode
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eptides [28]. Here, we describe three bi-functional bacterial sRNAs
hat have been functionally characterized.
.1. RNAIII
Staphylococcus aureus RNAIII was the ﬁrst bacterial sRNA
eported to have dual functions. S. aureus is a potent pathogen and
ts virulence is attributed to both cell surface-associated proteins
nd secreted toxins. The 5′ region of RNAIII encodes a secreted
6 aa peptide, -hemolysin (hld), which targets host cell mem-
ranes, causing lysis [29]. -hemolysin does not have any known
egulatory functions but RNAIII, a 514 nucleotide long sRNA, reg-
lates stability and translation of virulence factors by direct base
airing with the corresponding transcripts. The expression of cell
urface-associated factors is repressed at the end of exponential
rowth phase while that of secreted factors is stimulated [30,31].
his reciprocal regulation is carried out by the agr locus. RNAIII
RNA is the major effector of the agr response [32]. The 3′ region of
NAIII inhibits ribosomal binding and translation initiation of coag-
lase (an enzyme), staphylococcal protein a (a cell surface-associated
actor), and rot (a transcription factor). Consistently, this region of
he RNA is more conserved among different isolates of S. aureus
33–35]. The 5′ region of RNA III also functions by base-pairing
nd facilitates the translation of ˛-hemolysin (hla), a secreted factor
y preventing the formation of a translational inhibitory complex.
his region overlaps with the coding sequence of hld, hence the
ase pairing activity of RNAIII with mRNAs may  prevent transla-
ion of hld [36]. Such a mode of regulation is consistent with a delay
n accumulation of -hemolysin after RNAIII sRNA synthesis [37].
ence, it can be envisaged that hld is regulated at several levels and
here is a possible interplay between production of -hemolysin
nd the antisense functions of RNAIII.
.2. SgrS
SgrS (Sugar transport related), a 227-nucleotide sRNA, is
nduced during glucose-phosphate stress conditions resulting
rom disruption of glycolytic ﬂux and accumulation of glucose-6-
hosphate. SgrS actively alleviates stress by negatively regulating
he stability and translation of the major glucose transporters,
tsG and manXYZ, via base pairing [38,39]. In addition to this
ase-pairing antisense activity, SgrS codes for a 43-amino acid
eptide, SgrT [40]. Interestingly, SgrT also functions in the
lucose–phosphate stress response, but by unrelated mechanisms.
ctopic expression of SgrT from constructs lacking the base-pairing
equences eases the stress response while the stability of trans-
orters is not affected. It has been suggested that SgrT functions
y inhibiting the active components of glucose transported but
he precise mechanisms are not clearly understood [40]. Vander-
ool and colleagues identiﬁed a highly conserved 15-nucleotide
equence at the 3′ end of SgrS from several enteric species, even
hough the overall sequence was rather divergent [41]. These con-
erved nucleotides are complementary to the ribosomal binding
ite in ptsG mRNA, and hence base pairing leads to translation
epression and mRNA degradation (Fig. 2A) [42]. In case of manXYZ
olycistronic mRNAs, SgrS base pairs with the coding sequence of
anX leading to RNA degradation [38,39]. In contrast to RNAIII, the
egulatory sequences and coding sequences are spatially separated
n SgrS. The coupled degradation of SgrS during ribo-regulation sug-
ests that the two functions of SgrS are mutually exclusive and the
ame RNA molecule cannot serve as both ribo-regulator and a tem-
late for translation of SgrT. Further investigation is required to
tudy if there is any relationship between the regulatory function
nd translation of SgrS.elopmental Biology 47–48 (2015) 40–51
2.3. SR1
SR1 is a dual function RNA identiﬁed in the gram-positive bac-
terium, Bacillus subtilis. SR1 represses the translation of a transcrip-
tional activator ahrC that regulates the arginine catabolic operons,
rhoABC and rhoDEF [43]. There are seven regions of complemen-
tarity between SR1 and ahrC. SR1 binding inhibits translation of
ahrC mRNA by inducing structural changes downstream of the
ribosomal binding site [44]. In a quest to discover more targets
of SR1, Brantl and colleagues discovered that SR1 also regulates
the glycolytic gapA operon [45]. However, the mechanism of SR1-
mediated regulation of gapA is not by base pairing of the RNA.
SR1 encodes a 39-aa peptide (SR1P) that stabilizes gapA operon
RNA. SR1P was  reported to directly bind to GapA protein, but
the mechanisms underlying this mode of regulation are not fully
understood [45].
3. Bi-functional RNAs in plants
Plants exhibit a remarkable developmental plasticity and exten-
sively regulate their gene expression proﬁles in response to
environmental cues and stress. RNA-mediated regulation appears
to play a signiﬁcant role in adaptation to varying environmental
conditions [46]. Here, we  discuss two plant RNAs that code for
peptides and also have intrinsic function as RNAs.
3.1. ENOD40
Early nodulin 40 (ENOD40) is the best-studied example of a
cncRNA in plants. It was ﬁrst identiﬁed as a gene expressed during
early stages of root nodule formation, resulting from the sym-
biotic association of leguminous plants with rhizobial bacteria
[47]. ENOD40 is expressed in differentiating cells of nodule pri-
mordia and the expression levels of ENOD40 positively correlate
with the rate of nodulation in transgenic plants [48]. Due to the
absence of any long open reading frame (ORF) and the highly sta-
ble secondary structure of the RNA, ENOD40 was proposed to be
a non-coding RNA. However, the molecular mechanisms under-
lying its activity remained unclear for many years [49,50]. Later,
studies in Medicago truncatula (a model legume plant) showed
that there are two conserved short ORFs in the ENOD40 tran-
script and that the 5′ORF is highly conserved [51]. Transient
expression of ENOD40 in roots resulted in cortical cell divisions
at high frequency. By targeting wild type and truncated/mutated
ENOD40 to the cortical cells in roots, Crespi and colleagues showed
that translation of both short ORFs is required for the activity
of ENOD40. Interestingly, deletion of an inter-ORF region of the
RNA with a predicted secondary structure also affected the activ-
ity of ENOD40, without altering translation of the ORFs. These
results emphasized the importance of both the RNA structure
and short ORFs, and imply a dual role for ENOD40 RNA in plant
roots.
Yeast-three-hybrid studies showed that a novel protein,
MtRBP1, interacts with ENOD40 RNA. MtRBP1 was found to be cyto-
plasmic in nodule primordia cells expressing high levels of ENOD40,
whereas MtRBP1 localized to nuclear speckles in other root cells.
Consistent with this, upon expression of ENOD40 in heterologous
cells, MtRBP1 relocated from the nucleus to the cytoplasm. While
the short ORFs encoded by ENOD40 did not play a role in local-
ization of MtRBP1, the RNA was found to be directly required for
cytoplasmic localization of MtRBP1. The function of this RNP (ribo-
nucleo protein) is still unknown, although it has been proposed
to function as a translational regulator in the cytoplasm [52]. Fur-
thermore, in soybean, the two  short peptides encoded by ENOD40
bind to sucrose synthase (SUC1) and inhibit phosphorylation.
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Fig. 2. Regulatory functions of coding mRNAs. (A) Base pairing leads to RNA degradation/translational regulation.  Glucose phosphate stress (G-6-P) leads to activation of
transcription of a cncRNA, SgrS. The 5′ region of SgrS encodes for a short peptide (SgrT) while the 3′ region regulates the expression of ptsG mRNA by base pairing. The minimal
base  pairing region of SgrS RNA is underlined and the Shine–Dalagarno (SD) sequence of ptsG mRNA is highlighted. This base pairing leads to translational repression and
RNA  degradation. (B) Structural role of RNA in cytoskeletal organization. Here a Xenopus egg is depicted along the animal (A) – vegetal (V) axis and the vegetal cortex (boxed)
is  illustrated in detail. In Xenopus oocytes, cytokeratin (green ﬁlaments) form a complex interconnected network spanning between the cortical granules (brown) and the
yolk  granules (yellow) at the vegetal cortex. Germplasm islands (pink) are anchored at the vegetal pole by the cytokeratin network. Germinal granules (red) are located
within  these islands. Proper organization of cytokeratin network requires VegT RNA (blue). In VegT depleted oocytes, long cytokeratin ﬁlaments are disintegrated, and the
fragmented cytokeratin network affects germplasm distribution such that the islands and individual germinal granules fuse into larger aggregates. (C) RNA as a scaffold to
assemble regulatory complexes.  Several co-regulators participate in nuclear receptor signaling. In absence of ligand (L), repressors such as SHARP and SLIRP bind the nuclear
receptors (NR) and repress transcription by mobilizing histone deacytylases (HDAC). Upon ligand binding, the repressors are replaced by co-activators (e.g., SRC-1 and p300),
that  in turn recruit RNA polymerase II and initiate target gene expression. SRA, the RNA co-regulator is thought to function as a scaffold and brings the whole complex
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cogether at the nuclear response element (NRE) and facilitates gene regulation. (For
eb  version of this article.)
hosphorylated SUC1 undergoes proteasomal degradation. Thus,
NOD40 peptides regulate the turnover of SUC1. These diverse
unctions substantiate the bi-functional nature of ENOD40. Recent
tudies in Arabidopsis and rice have identiﬁed a number of RNAs
imilar to ENOD40 that can code for short ORFs [53,54]. It is con-
eivable that these are also potential cncRNAs.retation of the references to color in this ﬁgure legend, the reader is referred to the
3.2. MtHAP2-1It has been observed that short ORFs in the 5′UTR (upstream
ORF, uORF) of an RNA can contribute to gene regulation [55].
For instance, a HAP2 family transcription factor in M.  truncatula,
MtHAP2-1, is regulated by a peptide, uORF1p, which is encoded
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y its uORF. MtHAP2-1 is a key regulator in the nodule meristem
nd functions in nodule development. Alternative splicing of the
rst intron in the 5′UTR of MtHAP2 is predominant during nodula-
ion, and results in production of uORF1p. Unlike other uORFs that
egulate translation by ribosomal stalling, uORF1p represses trans-
ation by binding to the 5′UTR of MtHAP2-1 [56]. This regulation
s important for spatial regulation of MtHAP2-1 and nodulation.
ence, MtHAP2 is an example of a cncRNA whose alternative splic-
ng results in dual functions of the RNA.
.3. miRNA-encoded peptides (miPEPs)
A recent report from Combier and colleagues shows that some
re-miRNA transcripts in plants have functional ORFs [57]. The
ighly conserved pre-miRNA sequence of M.  truncatula miR171b
ith only 0.85% SNPs, suggested the possibility of ORFs in the
equence. Indeed, two ORFs were found in the 5′ region of pre-
iRNA 171b, encoding short peptides of 5 and 20 amino acid
esidues, respectively. Further analysis with a -glucuronidase
GUS) reporter showed that only the ORF encoding 20-amino acid
eptide named as miPEP171b is expressed and translated at the
ateral root initiation site. Interestingly, miPEP171b speciﬁcally
nhances the expression of miR171b, and not other miRNAs when
verexpressed as pre-miRNA in M.  truncatula roots and in tobacco
eaves. Addition of synthetic miPEP171b to the seedlings of M. trun-
atula increased the levels of miR171b and affected lateral root
evelopment. Analysis of 50 pre-miRNA sequences from Arabidop-
is thaliana showed presence of at least one ORF in each sequence
58]. Interestingly, overexpression of various miPEPs encoded by
re-miRNA of different classed in M.  truncatula and A. thaliana,
ositively correlated with accumulation of corresponding miRNAs.
nhibition of RNA synthesis during overexpression of miPEPs and
nalysis in RNA polymerase subunit mutants suggest that miPEPs
unction as transcriptional regulators of the corresponding miRNAs
57]. Further studies are required to understand how cytoplasmic
ranslation of pre-miRNA and nuclear maturation of miRNAs is reg-
lated. The discovery of miPEPs further strengthens the concept of
i-functional cncRNAs, and it will be interesting to determine if
iPEPs exist in other organisms.
. Bi-functional RNAs in animal development
Early embryogenesis of many animals relies on a large number of
ranscripts maternally deposited in the oocytes and mediating ﬁrst
teps of development prior to commencement of the zygotic gene
xpression program. Some of these maternal RNAs are required for
ocyte maturation while others are stored in the form of mRNPs
nd are translated and/or degraded in an orchestrated manner
uring early phases of embryonic development. Hence, maternally
eposited RNAs are under tight post-transcriptional regulation that
ncludes regulated processing, localization and translation [59–63].
t is widely believed that the major biological function of localiza-
ion and translational control of RNAs in oocytes and embryos is
patial and temporal regulation of the corresponding protein prod-
ct. However, studies in Xenopus, Drosophila and more recently in
ebraﬁsh suggest that besides coding for proteins, localized RNAs
an have additional non-coding functions.
.1. Xenopus VegT
VegT was identiﬁed as a maternal RNA localized to the vegetal
ortex Xenopus laevis oocytes. VegT codes for a T-box transcription
actor that patterns the mesendoderm along the dorso-ventral axis
64]. Heasman et al. ﬁrst reported that depletion of VegT mRNA
eads to disruption of vegetal localization of maternal mRNAs such
s Vg1 [65]. Following this, Kloc and colleagues discovered thatelopmental Biology 47–48 (2015) 40–51
VegT mRNA and a non-coding RNA Xlsirts, play structural roles
in the organization of the cytoskeleton at the vegetal cortex of
Xenopus oocytes, and that the vegetal cytoskeleton is important for
anchorage of germ-line speciﬁc RNAs and formation of the germinal
granules [66]. Depletion of either VegT or Xlsirts RNA by injection
of antisense oligonucleotides speciﬁcally disrupted the cytokeratin
network at the vegetal cortex. However, translation-blocking anti-
sense morpholinos against VegT mRNA did not affect cytokeratin
structure. Additionally, upon injection of synthetic VegT mRNA into
the VegT depleted oocytes, the cytokeratin structure was restored.
These lines of evidences suggested that VegT has an mRNA-intrinsic
function. [66,67]. Further studies by Kloc and colleagues to ana-
lyze the three dimensional ultra-structure of cytoskeleton showed
that VegT mRNA molecules are integrated into the multilayered
cytoskeleton which collapses and disintegrates in the absence of
RNA. The integrity of the cytoskeleton is important for correct dis-
tribution of the germ plasm and germinal granules at the vegetal
cortex (Fig. 2B). Based on these ﬁndings, VegT mRNA has been sug-
gested to have a structural function in germ-line development,
independent of the function of VegT protein in germ layer pattern-
ing [67].
4.2. Drosophila oskar
Oskar (osk) was identiﬁed as a maternal-effect gene required
for antero–posterior patterning during Drosophila embryogenesis
[68]. During early oogenesis, osk mRNA is transported from nurse
cells to the developing oocyte. Subsequently, osk mRNA is actively
transported to the posterior pole, where Osk protein is exclusively
synthesized from localized osk RNA. Prior to localization, osk mRNA
is translationally repressed by Cup, a 4E binding protein. Cup regu-
lates osk mRNA by interacting with an RNA-binding protein, Bruno,
which recognizes speciﬁc sequence motifs in osk mRNA. Cup com-
petes with eIF4G for binding to eIF4E, the protein that binds to the
7-methyl-guanosine cap structure in mRNAs. Interactions between
eIF4G and eIF4E are required for ribosomes to load on mRNAs,
so sequestration of eIF4E by Cup blocks translation [69]. Posterior
localization and localized translation of osk mRNA determines the
site for formation of primordial germ cells and the abdomen. Osk
protein is known to regulate its own RNA localization and func-
tions as a scaffold for the assembly of the germ plasm [70,71]. The
classical osk mutants identiﬁed in the maternal effect screen that
produced embryos lacking abdomen and germ cells lacked func-
tional Osk protein but still expressed mRNA [72]. Surprisingly, two
new osk alleles with reduced or no osk mRNA showed more severe
and earlier defects during oogenesis compared to osk alleles that
express mRNA. Females harboring RNA null mutations failed to lay
eggs and were sterile as a result of an early arrest during oogenesis
[73]. The oogenesis arrest was complemented by nonsense mutant
alleles which still expressed osk mRNA, suggesting that the early
oogenesis function of osk is mediated by osk RNA and not Osk pro-
tein. To conﬁrm this possibility, in a series of elegant experiments,
Ephrussi and colleagues showed that overexpression of merely the
osk 3′UTR was  sufﬁcient to rescue the eggless phenotype of osk
RNA-null mutants. Therefore, they suggested that the osk 3′UTR
might function as a scaffold to assemble RNP complexes that are
required for oocyte development [73]. In agreement, a recent study
shows that loss of oskar RNA leads to accumulation of germline reg-
ulatory factors in the somatic follicle cells and speciﬁc elements in
the oskar 3′UTR sequester the translation regulator, Bruno in the
oocyte [74]. Taken together, these studies show that osk functions
as a protein coding-mRNA during embryogenesis and a non-coding
RNA during early oogenesis, and hence qualiﬁes as a cncRNA. The
molecular mechanisms underlying the non-coding function of osk
RNA are just beginning to be understood.
& Developmental Biology 47–48 (2015) 40–51 45
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Fig. 3. RNA processing facilitates dual function of cncRNAs. (A) Regulated splicing,
polyadenylation, and translation in temporal partitioning of non-coding versus cod-
ing functions of sqt RNA in zebraﬁsh. A 4-cell stage zebraﬁsh embryo is depicted with
dorsal progenitor cells (D) at the right side. In wild-type embryos, by the 4-cell stage,
sqt  transcripts are actively localized to 1 or 2 cells. In the schematic representation
of sqt RNA, black lines represent UTRs, blue boxes represent the 3 coding exons and
the  blue lines represent the introns. Maternal RNA is not completely spliced, lacks
a  poly A tail and is translationally repressed by Ybx1. Ybx1 sequesters eIF4E (4E)
either directly or in a complex with an eIF4E binding protein (4EBP) to prevent for-
mation of the eIF4 translation pre-initiation complex and recruitment of ribosomes
(R).  In maternal ybx1 mutant (Mybx1) embryos, sqt RNA fails to localize and forms
aggregates in the yolk. Maternal sqt RNA is precociously spliced, polyadenylated,
and Sqt protein is translated prematurely in Mybx1 mutant embryos. This leads to
premature activation of the Nodal/Squint pathway in Mybx1 mutants. (B) Alterna-
tive transcription start sites, intron retention and alternative splicing result coding
and non-coding isoforms of SRA RNA. The SRA genomic locus consists of ﬁve coding
exons, and exon I has two in-frame start codons (red asterisks). There is an alter-
native transcriptional start site (TSS) in exon I which leads to the production of a
non-coding isoform of SRA. Alternative splicing leads to retention of intron I andP. Kumari, K. Sampath / Seminars in Cell 
.3. Zebraﬁsh squint
Squint (Sqt) is a Nodal-related signaling molecule belonging to
he transforming growth factor beta (TGF) superfamily. Nodal
ignaling plays important roles during embryonic development
ith essential functions in germ layer patterning [75,76]. The
ole of Nodal signaling in mesendoderm induction and patterning,
peciﬁcation of the ventral neural tube, and left–right axis spec-
ﬁcation has been well studied [75,77–81]. In addition to these
nown roles, we discovered a novel non-coding function of asym-
etrically localized maternal sqt/nodal transcripts in dorsal axis
peciﬁcation [82,83]. In mature oocytes, sqt transcripts are dis-
ributed uniformly throughout the yolk, and form discrete puncta
pon egg activation and fertilization. Subsequently, these sqt RNA
uncta form bigger aggregates and translocate to the blastoderm
y a microtubule-dependent mechanism [84]. By the 4-cell stage,
qt RNA is asymmetrically localized to one or two cells and the
ells acquiring sqt RNA are required for the formation of dorsal
tructures [82]. Removal of sqt-containing cells or depletion of
aternal sqt by anti-sense oligonucleotides resulted in embryos
ith severe deﬁciencies in embryonic dorsal structures. These
xperiments suggested that asymmetrically localized sqt RNA may
unction in dorsal axis speciﬁcation. However, embryos obtained
rom homozygous insertion mutants affecting sqt exhibit mild dor-
al defects, raising questions regarding the contribution of maternal
qt in dorsal speciﬁcation [85,86]. Interestingly, we observed that
hile the insertion mutants for sqt do not make functional pro-
ein, mutant sqt RNA is expressed and localized in homozygous
qt insertion mutant embryos. Furthermore, mutant sqt transcripts
xpand dorsal progenitors in early zebraﬁsh embryos. Using a vari-
ty of mutations that disrupt Sqt protein, we showed that sqt RNA
unctions in the initiation of embryonic dorsal, independent of Sqt
rotein. Over-expression of the sqt 3′UTR sequences rescues the
orsal defects resulting from depletion of maternal sqt. Subsequent
nalysis of sqt RNA function in maternal mutants affecting Wnt
nd Nodal signaling showed that the dorsalizing function of the sqt
′UTR requires Wnt/ catenin signaling [83], but Nodal signaling
er se is not required for initiation of dorsal speciﬁcation. These
ndings are consistent with the requirement of Nodal receptors and
he Nodal co-receptor, One-eyed pinhead (Oep), from late blastula
tages [87,88]. Based on these results we proposed a role for mater-
al sqt RNA in binding and transporting factor(s) via its 3′UTR, to the
uture dorsal side during early blastula stages prior to the signaling
unctions of Sqt protein. Such a binding factor (or complex) is likely
o function via the canonical Wnt/ catenin pathway. Identiﬁcation
f the factors that bind to sqt 3′UTR can provide insights into the
echanisms by which sqt RNA and particularly the 3′UTR controls
orsal axis formation via Wnt  signaling.
We  also uncovered another level of regulation that likely
ontrols the coding and non-coding functions of sqt in a spatial
nd temporal manner. Consistent with the non-coding function
f sqt RNA in early embryos, maternal sqt RNA is translationally
epressed during early cleavage stages [89]. Y-box binding protein
 (Ybx1), a conserved nucleic acid binding protein, is required for
orsal localization of sqt and translational control of Sqt/Nodal
ignaling in early zebraﬁsh embryos. Ybx1 binds to a localization
lement in the sqt 3′UTR, and to cap-binding protein eIF4E, and
revents Sqt protein translation in early embryos. Maternal sqt
NA is deposited in an unprocessed form in the egg, i.e., it is
n-spliced and non-polyadenylated [83,90]. The RNA gets com-
letely processed only by the 16-cell stage. In contrast, spliced
nd polyadenylated sqt was detected in embryos obtained from
omozygous ybx1 females as early as the one-cell stage, indicating
remature processing of the mRNA in mutant embryos. Consistent
ith this observation, Sqt protein is precociously translated in
aternal ybx1 mutants compared to wild-type embryos. Thissometimes intron III, and can also produce non-coding SRA isoforms. (For interpre-
tation of the references to color in this ﬁgure legend, the reader is referred to the
web version of this article.)
leads to premature and deregulated Squint/Nodal signaling, which
is catastrophic for embryonic development and maternal ybx1
mutants typically do not survive beyond early gastrula stages [89].
Thus, sqt mRNA presents an example of a cncRNA where RNA
processing and translation regulate the coding and non-coding
functions of the RNA, such that they are temporally distinct events
during embryonic development (Fig. 3A).
5. Epigenetic regulation by RNAs
RNA molecules actively participate in epigenetic regulation by
physically interacting with chromatin modifying enzymes. They
are involved in modiﬁcation of histones and DNA methylation [91].
Studies so far suggest that RNA-mediated epigenetic regulation is
carried out for the most part by nuclear lncRNAs and lncRNAs have
been shown to function as both activators (HOTTIP, Mistral, etc.) and
repressors (HOTAIR, ANRIL,  Xist, etc.) (reviewed in [92,93]). How-
ever, recent data from Coolen and Esteller laboratories suggests
that coding RNAs may  also be involved in epigenetic regulation
[94]. By speciﬁcally looking for RNAs that are bound to SUZ12,
a component of the polycomb repressive complex 2 (PRC2), in
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hemically cross-linked samples of human prostate cancer cell
ines, Coolen and colleagues identiﬁed a number of protein coding
NAs that bind to SUZ12 with afﬁnities comparable to that of lncR-
As [94]. They also re-analyzed a similar data set from the Esteller
ab where RNAs bound to EZH2, another component of PRC2,
ere immune-precipitated and sequenced, and identiﬁed protein-
oding RNAs [95]. This study was performed in human colorectal
ancer cell lines. Analysis of RNA-sequencing data obtained from
ouse embryonic stem cells also identiﬁed protein-coding RNAs
hat bind to EZH2 [96]. Although the functional signiﬁcance of such
RC2-mRNA interaction are yet to be discovered, taken together
hese studies suggest that even protein-coding RNAs can partici-
ate in epigenetic regulation.
. Bi-functional RNAs in disease
Mutations leading to dysfunctional RNAs can lead to a variety of
uman diseases ranging from neuro-degeneration to cancer. Here,
e describe the pathological function of some RNAs independent
f their protein function.
.1. SRA, a dual function co-regulator of transcription factors
Steroid receptor RNA Activator (SRA) was the ﬁrst mammalian
NA to be discovered with dual roles, protein coding and non-
oding, in myogenic differentiation [97]. SRA was initially identiﬁed
s a partner of progesterone receptor with co-regulatory functions
98]. Despite the presence of a long ORF, Lanz and colleagues did
ot detect a protein product encoded by SRA mRNA. They then
ested the ability of SRA to co-activate glucocorticoid receptor in
he presence of a de novo protein synthesis inhibitor, cyclohex-
mide and concluded that SRA functions as an RNA co-activator of
uclear receptors [98]. Soon thereafter, a number of studies demon-
trated that SRA co-activates many nuclear receptors including the
strogen, androgen, gluco-corticoid and retinoic acid receptors.
econdary structure prediction of SRA RNA followed by muta-
ional analysis suggested the presence of multiple stem loops in
RA RNA that are required for its activity [99]. SRA functions as
 scaffold that brings together transcriptional co-activators, RNA
olymerase as well as gene insulators/repressors (reviewed in
100–102]) (Fig. 2C). The activity of transcription factors such as
yoD and GATA-3 is also enhanced by SRA RNA [103,104]. Sub-
equent sequence analysis to identify the transcription start site
howed the presence of a novel isoform of SRA, containing an addi-
ional 5′ exon. The 5′ exon contains two ATG start codons in the
ame frame that could potentially lead to the translation of either
 224 or a 236-aa SRA peptide (SRAP). The authors conﬁrmed the
resence of the coding RNA isoform and doublet of correspond-
ng peptides by reverse transcription and western blot analysis
espectively [97]. Differential transcriptional start site and alter-
ative splicing, resulting in either retention or exclusion of the
rst and sometimes third intron, determines whether SRA func-
ions as a coding or a non-coding RNA (Fig. 3B) [105,106]. SRAP is
onserved among chordates and one of the domains found in all
nnotated SRAPs contains a RNA recognition motif (RRM), a puta-
ive nuclear localization signal and a motif that might interact with
uclear receptors [107]. Using silent mutations that disrupted reg-
latory motifs in SRA RNA and nonsense mutations that disrupted
RAP, it was established that SRAP functions in both activator and
epressor complexes of nuclear receptors, independent of SRA RNA
108–110]. In contrast, muscle differentiation studies showed that
RAP prevented SRA RNA-dependent activation of MyoD [103].
Interestingly, SRA RNA is expressed at higher levels in human
reast tumors as compared to adjacent tissues, and the levels
ncrease with tumor progression [111,112]. SRA ncRNA and SRAPelopmental Biology 47–48 (2015) 40–51
co-exist in breast cancer cell lines and the relative expression of the
two molecules differs in different phenotypes, with higher levels of
non-coding SRA detected in invasive cell lines. This suggests that
the balance between the two isoforms might deﬁne tumor phen-
otypes and alter gene expression during tumor progression [113].
These data also highlight the role of alternative splicing in tumor
metastasis. SRAP is known to function as a co-activator of androgen
receptors in prostate cancer. However, its precise role in tumor pro-
gression in this context is not fully understood, and it is unknown
if non-coding SRA RNA has a role in prostrate tumors [108,114].
Taken together these studies show that the SRA locus codes for
various SRA RNA isoforms that have either coding or non-coding
functions, and that in some contexts, the coding and non-coding
functions can be intertwined. Importantly, the balance of SRA iso-
forms is relevant to both normal differentiation and disease.
6.2. DMPK in myotonic dystrophy
Myotonic dystrophy (DM) is an autosomal dominant inherited
disease characterized by slow progressing multi-systemic symp-
toms like muscle wasting, myotonia, cardiac defects and reduced
cognitive ability. By positional cloning, the DM1  mutation associ-
ated with type 1 myotonic dystrophy was  identiﬁed as a variable
length polymorphism which resulted from increased number of
trinucleotide CUG repeats in the 3′UTR of DM protein kinase (DMPK)
expressed in tissues affected by myotonic dystrophy [115,116].
The severity of clinical symptoms of myotonic dystrophy correlates
with the number of CTG repeats found in patients [117,118]. Unaf-
fected individuals have less than 38 repeats whereas patients have
between 50 and 1500 repeats. Mutant DMPK mRNA with expanded
CUG repeats (CUGexp-RNAs) is transcribed but the transcripts
are sequestered as discrete foci in nuclei leading to cytoplasmic
depletion of DMPK mRNA [119]. Haplo-deﬁciency of DMPK protein
and/or SIX5 encoded by the downstream gene leads to delayed
onset of mild symptoms, but were not found to be completely
responsible for DM1  phenotypes [120,121]. However, recent evi-
dence suggests that the DM1  pathology involves a toxic gain
of function by mutant CUGexp-RNA. Structural and biochemical
experiments showed that the CUG repeats form a stable hairpin
structure [122,123]. Moreover, CUGexp-RNA is not transported
to the cytoplasm and forms discrete aggregates at the periphery
of nuclear speckles, which are structures enriched with splicing
related factors [124]. The hairpin structure sequesters develop-
mentally regulated splicing factors like MBNL (Muscle blind like)
[125]. Another splicing factor, CELF1 (CUGBP1) also bind to single
stranded CUG sequences but do not co-localize with the nuclear
aggregates of CUGexp-RNAs. However, expression of CUGexp-
RNA leads to hyper-phosphorylation and stabilization of CELF1
[126,127]. Mis-regulation of MBNL and CELF1 disrupts splicing of
a subset of RNAs and lead to embryonic splicing patterns in adult
tissue, and hence has a primary role in development of myotonic
dystrophy [128]. Thus, repeat expansion of certain nucleotides
can convert an mRNA into a functional RNA implicated in protein
sequestration and human disease (Fig. 4A). Expansion of similar
triplets (CGG, GAA), which are capable of base pairing, in other
RNAs have been found associated with a number of other human
diseases such as fragile X tremor ataxia syndrome and Friedreich
ataxia [129].
6.3. p53 RNA in mammalian breast cancer cells
Disruption of p53, a critical tumor suppressor gene, is the most
frequent single gene event leading to human cancers. The p53
protein is post-translationally modiﬁed and rendered active as a
transcription factor in response to stresses such as DNA-damage,
hypoxia, nutrient deprivation and telomere damage which can
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Fig. 4. cncRNAs in disease. (A) Sequestration and modulation of regulatory proteins by DMPK mutant RNA in type I myotonic dystrophy.  Variable length polymorphism resulting
from  increased number of CUG repeats in 3′UTR of DMPK gene leads to transcription of a toxic form of RNA (DMPK CUGexp-RNA). The CUG repeats form a stable stem
loop  (the hairpin in the DMPK CUGexp-RNA). The splicing factor MNBL (yellow) directly binds to the CUG repeats. Sequestration of MBNL makes it inactive. DMPK CUG-exp
RNA  stabilizes another splicing factor, CELF1 by indirect hyperphosphorylation. This leads to mis-regulation of alternative splicing and manifestation of type I myotonic
dystrophy (DMI) symptoms. (B) ceRNAs as miRNA sponge.  A group of mRNAs sharing a particular miRNA response element (MRE) function as ceRNAs and inﬂuence each
other’s translation. In a normal state, a limited pool of miRNAs can regulate the translation of a number of mRNAs in a ceRNA network. When the expression of one mRNA is
changed, the redistribution of available miRNA molecules will result in a change in translational output of other mRNAs in the network, potentially leading to disease states.
In  this schematic, ORF2 functions as a miRNA sponge to regulate the translational output of ORF1 and ORF3. When ORF2 expression is reduced (disease state i) miRNA that
was  bound to ORF2 will be available to target other RNAs leading to repression of ORF1 and ORF3 while when ORF2 is overexpressed (disease state ii), translational repression
of  ORF1 and ORF3 by miRNA will be alleviated due to presence of more MREs. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the
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ead to cancer. Activated p53 initiates a program of cell cycle
rrest and apoptosis [130,131]. The p53 protein is expressed as
t-least four different isoforms resulting from alternative initia-
ion codons. These isoforms were found differentially expressed
n human breast cancer samples as compared to normal breast tis-
ue [132,133]. Mdm2,  an E3 ubiquitin ligase is a major regulator of
53 protein and prevents excessive and persistent p53 activationvia a feedback regulation [134,135]. Recently, it was  shown that
there is an additional feed forward regulation, wherein p53 mRNA
interacts with Mdm2  and leads to enhanced p53 translation and
stabilization [136]. Mdm2  associates with p53 polysomes via its
RING domain and probably enhances translation. Consistent with
this possibility, a CUA to CUG mutation in p53 was identiﬁed in
a lymphocytic leukemia patient where mutant p53 was found to
48 P. Kumari, K. Sampath / Seminars in Cell & Developmental Biology 47–48 (2015) 40–51
Fig. 5. Binary phenotypes – protein null versus RNA null. Normal transcription and translation of a cncRNA will result in wild-type phenotype. Mis-sense or insertion
mutations in the genome can result in mutant RNA (red asterisk) that might be stable if not targeted by non-sense mediated decay pathway, and can carry out the non-coding
function. So, a protein mutant phenotype will be observed without affecting the activity of the RNA. But mutations that eliminate the transcript (transcription start site or TSS
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iutations and gene deletions) or antisense oligos that degrade RNA will lead to a bi
f  the references to color in this ﬁgure legend, the reader is referred to the web  ver
mpair Mdm2-mediated enhancement of p53 translation [137]. p53
RNA recruits Mdm2  to p53 polysomes where the latter likely
unctions as a chaperone for p53 protein folding. During this pro-
ess, the E3 ligase activity of Mdm2  is inhibited [136,138]. Thus,
53 mRNA acts as a switch that controls Mdm2  regulation of p53
rotein. Interestingly, the region of p53 mRNA that encodes for the
dm2  binding site in p53 protein, also interacts with the RING
omain of Mdm-2  [136]. This is an example where the same region
f RNA mediates both coding and non-coding functions. Mutations
n such RNAs should be designed carefully because they have the
otential to affect both the activity of the RNA and the encoded
rotein and lead to binary phenotypes.
.4. Competing endogenous RNAs in cancer
Coding and non-coding transcripts can function as a sponge to
ind miRNAs and alleviate the repressive activity of miRNAs on the
arget mRNAs. Such RNAs that regulate the activity of other RNAs
y directly competing for miRNA binding are named as competing
ndogenous RNAs (ceRNAs) and any perturbation in their levels
an lead to disease states [139] (Fig. 4B). One of the best-studied
xamples of ceRNA regulatory networks is one encompassing the
umor suppressor gene PTEN. PTEN encodes a phosphatase that
ntagonizes the highly oncogenic PI3K/Akt signaling pathway.
arious co-expressed RNAs like VAPA, CNOT6L and PTENP1 (a non-
oding pseudogene of PTEN) were found to share miRNA response
lements (MREs) with PTEN. Their RNAs were shown to relieve
iRNA-mediated repression of PTEN. Consistently, Pandolﬁ and
olleagues showed that copy number loss of these ceRNAs during
ancer promotes tumorigenesis by repressing PTEN. These interac-
ions were shown to be reciprocal as PTEN mRNA can also regulate
he expression of VAPA protein [140]. Thus, the ceRNAs exhibit a
egulatory function in addition to their protein coding function.
any such RNAs that function in a miRNA dependent cross-talk
nd their regulatory functions in tumor suppression have been
dentiﬁed (reviewed in [141,142]).henotype resulting from loss of both RNA and protein function. (For interpretation
f this article.)
7. Conclusion and perspectives
Here, we reviewed the emerging class of bi-functional RNAs that
combine protein-coding and noncoding functions in a single RNA
molecule. The current list of these molecules might be limited,
but phylogenetic analysis and RNA structure predictions suggest
that this list is likely to expand in the future [143,144]. Indeed, a
large number of ncRNAs lacking canonical ORFs are transcribed by
polymerase II, spliced, capped and polyadenylated just like mRNAs
[145,146]. It remains an open question what fraction of these can
be translated into short functional polypeptides. On the other hand,
the protein-centric view that has dominated molecular biology
since its inception might have biased characterization of mRNAs
to their ‘information messenger’ role leaving a wealth of struc-
tural and/or regulatory functions largely unexplored. An important
future challenge will be to understand how these cncRNAs balance
their coding versus non-coding capacities. Do they partition the two
functions to physically distinct domains (as exempliﬁed by bacte-
rial SgrS, Drosophila osk and zebraﬁsh sqt) or alternatively, do they
utilize the primary sequence for encoding proteins while reserving
the secondary or tertiary structure of the same region for non-
coding roles? Determining cncRNA conformation using emerging
experimental approaches [147,148] should improve our under-
standing of how these varied functions are elicited. In addition, for
many of the known cncRNAs such as SRA RNA, regulated processing
events such as alternative splicing, cleavage and polyadenylation
underlie their ability to perform coding versus non-coding func-
tions. A recent study suggested that about 300 alternatively spliced
bi-functional RNAs might exist in the human genome [149]. There-
fore, we  propose that the loss of RNA function phenotypes be
examined for identifying new cncRNA loci, as protein-null phen-
otypes might be distinct from the RNA-null mutants (Fig. 5). An
important future direction will be teasing apart protein-coding and
non-coding functions for cncRNA loci using appropriate genome
editing methods [150,151]. This would require careful design
of genomic lesions to speciﬁcally test phenotypic consequence
of impaired ORF and ncRNA moieties. The identiﬁcation and
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haracterization of novel cncRNAs and the mechanisms by which
hey elicit their various functions, can provide new insights into
ene regulation in the context of normal homeostasis and disease
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